GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
QUESTOR PHARMACEUTCL (QCOR) [hlAlert]

Rating:
Buy QCOR
up 1,513.79 %

QUESTOR PHARMACEUTCL (QCOR) rated Buy by Soleil

Posted on: Thursday,  Sep 11, 2008  10:25 AM ET by Soleil

Soleil rated Buy QUESTOR PHARMACEUTCL (NASDAQ: QCOR) on 09/11/2008, when the stock price was $5.80. Since
then, QUESTOR PHARMACEUTCL has gained 1513.79% as of 08/14/2014's recent price of $93.60.
If you would have followed this Soleil's recommendation on QCOR, you would have gained 1513.79% of your investment in 2163 days.

Questcor Pharmaceuticals, Inc. (Questcor) markets H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS), and the treatment of nephrotic syndrome. H.P. Acthar Gel (Acthar) is not indicated for, but is also used in treating patients with infantile spasms (IS). The Company also markets Doral (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. As of December 31, 2008, Acthar was approved in the United States for the treatment of exacerbations associated with MS, nephrotic syndrome and many other conditions with an inflammatory component.

Soleil focuses on institutional research without ties to proprietary trading. By aggregating unbiased, actionable research, we allow our institutional clients to access a variety of perspectives and investment opinions from one trusted source. Our experienced sales professionals and research production team evaluate and filter dozens of independent research analysts to create a select group of research partners that best serve our clients. Each of our analysts has considerable industry experience, significant institutional relationships, a deep understanding of a particular sector, and the ability to deliver proprietary data and insights. Through expanded coverage of conventional and under-followed companies, they provide multiple perspectives and divergent viewpoints across a variety of industry sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/11/2008 10:25 AM Buy
None
5.80
as of 12/24/2008
1 Week down  -14.95 %
1 Month up  0.44 %
3 Months down  -30.32 %
1 YTD down  -51.12 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy